Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$142,458,885
+$7,902,706 QoQ
Shares Held
4,203,567
0.0% QoQ
Ownership
3.52%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#7
of 198 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VIKING GLOBAL INVESTORS LP holds $2,489,856,848 across 17 Biotechnology names. NAMS ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
9,949,219 | $741,017,831 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
7,616,563 | $435,819,734 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
6,271,467 | $221,947,217 | |
| 4 | MANE |
Veradermics, Inc
|
1,561,494 | $191,970,072 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
1,503,478 | $143,086,001 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
4,203,567 | $142,458,885 | |
| 7 | SION |
Sionna Therapeutics, Inc.
|
3,195,181 | $140,556,012 | |
| 8 | PHVS |
Pharvaris N.V.
|
3,653,310 | $126,331,459 |
All Filings in NAMS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $142,458,885 | 4,203,567 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $134,556,179 | 4,203,567 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $147,461,130 | 4,203,567 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $184,164,186 | 6,475,534 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $126,381,250 | 6,978,534 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $142,850,590 | 6,978,534 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $179,348,323 | 6,978,534 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $179,348,323 | 6,978,534 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $133,207,779 | 8,024,565 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $154,151,893 | 8,024,565 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $189,780,962 | 8,024,565 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $89,634,391 | 8,024,565 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $74,227,226 | 8,024,565 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $77,577,077 | 6,524,565 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $51,924,436 | 3,915,870 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $40,916,725 | 3,753,828 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||